Can vaccination produce protective antibodies in people who fail to develop protective antibodies after recovery from COVID-19 infectio
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
HCW
Employed at RGCI
Either sex
18-70 years
History of positive RT-PCR test for SARS-CoV-2
Either undetectable ( <1AU) or very low ( < 4.62 AU) IgG antibody titre
Vaccinated
Exclusion Criteria
Non Health Care Worker
Not an employee of Rajiv Gandhi Cancer Institute
Not vaccinated against COVID-19
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IgG antibody titreTimepoint: 7-14 days post first dose of vaccination <br/ ><br>28 days post second dose of vaccination
- Secondary Outcome Measures
Name Time Method Any other symptomTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;ChillsTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;FeverTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;HeadacheTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;MalaiseTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;MedicationTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;MyalgiaTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;Pain at injection siteTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination;RashesTimepoint: Post first dose of vaccination <br/ ><br>Post second dose of vaccination